{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T21:05:48Z","timestamp":1766869548679},"reference-count":32,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2004,10,8]],"date-time":"2004-10-08T00:00:00Z","timestamp":1097193600000},"content-version":"vor","delay-in-days":2352,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Neurology"],"published-print":{"date-parts":[[1998,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>From using in vitro intracellular recordings from mesencephalic neurons and monoamine\u2010depleted rats, we report that the functions of levodopa in the brain are greatly enhanced and prolonged by high does of the monoamine oxidase (MAO) inhibitor deprenyl. Dopaminergic neurons were hyperpolarized and inhibited by levodopa application. These effects of levodopa were largely potentiated by pretreatment with nonselective does of deprenyl. Furthermore, when locomotor activity induced by levodopa was examined on a rodent model of parkinson's disease, pretreatment of the animals with nonselective doses of deprenyl caused an enhancement of the antiparkinsonian action of levodopa. The great increase in levodopa responses by deprenyl suggests a likely therapeutic use of this dopamine precursor with a higher dosage of the MAO inhibitor, to reduce effectively the daily levodopa requirements in Parkinson's disease patients.<\/jats:p>","DOI":"10.1002\/ana.410430509","type":"journal-article","created":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T15:15:36Z","timestamp":1104592536000},"page":"613-617","source":"Crossref","is-referenced-by-count":6,"title":["Modification of levodopa responses by deprenyl (selegiline): An electrophysiological and behavioral study in the rat relevant to Parkinson's disease"],"prefix":"10.1002","volume":"43","author":[{"given":"Nicola B.","family":"Mercuri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangela","family":"Scarponi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Federici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonello","family":"Bonci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Siniscalchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,10,8]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01246955"},{"key":"e_1_2_1_3_2","first-page":"45","article-title":"(\u2013\u2010)\u2010Deprenyl (selegiline, Movergan ) facilitates the activity of the nigrostriatal dopaminergic neurons","volume":"25","author":"Knoll JR","year":"1987","journal-title":"J Neural Transm"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410370117"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01253131"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2502843"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1989.00520480022013"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1041416"},{"key":"e_1_2_1_9_2","first-page":"733","article-title":"The monoamine oxidase of brain: selective inhibition with drugs and the consequence for the metabolism of biogenic amine","volume":"189","author":"Yang HY","year":"1974","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.17-07-02267.1997"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.1995.tb00342.x"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1984.tb16228.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410350605"},{"key":"e_1_2_1_14_2","first-page":"393","volume-title":"Monoamine oxidase\u2013\u2010new vistas","author":"Knoll J","year":"1972"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.09-04-01233.1989"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.09-10-03463.1989"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1990.tb15792.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1996.tb15222.x"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1990.tb04587.x"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(78)90525-7"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01271567"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1995.65031213.x"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1978.tb00883.x"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02251224"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410250509"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.1994.tb00584.x"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-199608000-00012"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(96)00761-5"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950080019003"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291408"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.09-09-03326.1989"},{"key":"e_1_2_1_32_2","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.1523\/JNEUROSCI.15-09-06157.1995","article-title":"Activation of dopamine cell firing by repeated L\u2010dopa administration to dopamine\u2010depleted rats: its potential role in mediating the therapeutic response to L\u2010dopa treatment","volume":"15","author":"Harden DG","year":"1995","journal-title":"J Neurosci"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(97)01079-1"}],"container-title":["Annals of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fana.410430509","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ana.410430509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T21:16:09Z","timestamp":1698527769000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ana.410430509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,5]]}},"alternative-id":["10.1002\/ana.410430509"],"URL":"https:\/\/doi.org\/10.1002\/ana.410430509","archive":["Portico"],"relation":{},"ISSN":["0364-5134","1531-8249"],"issn-type":[{"value":"0364-5134","type":"print"},{"value":"1531-8249","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,5]]}}}